IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway
Article in Epigenetics (October 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Epigenetics (October 2023)
Article in Medicine (April 2023)
Article in International Journal of Immunopathology and Pharmacology (March 2022)